Market Cap 2.02B
Revenue (ttm) 714.73M
Net Income (ttm) 145.49M
EPS (ttm) N/A
PE Ratio 13.48
Forward PE 10.74
Profit Margin 20.36%
Debt to Equity Ratio 0.24
Volume 441,100
Avg Vol 700,500
Day's Range N/A - N/A
Shares Out 57.42M
Stochastic %K 64%
Beta 0.87
Analysts Strong Sell
Price Target $51.44

Latest News on HRMY

Harmony Biosciences: A Compelling Risk-Reward Opportunity

Mar 24, 2025, 12:09 PM EDT - 2 months ago

Harmony Biosciences: A Compelling Risk-Reward Opportunity